P-glycoprotein | inhibitor | Acetylcholinesterase inhibitor | glycoprotein | Selective serotonin reuptake inhibitor | P-selectin glycoprotein ligand-1 | Glycoprotein | Enzyme inhibitor | enzyme inhibitor | Variable surface glycoprotein | Metalloprotease inhibitor | Matrix metalloproteinase inhibitor | Inhibitor | Glycoprotein IIb/IIIa | Farnesyltransferase inhibitor | COX-2 inhibitor | ALK inhibitor | ACE inhibitor |
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.
Glycoprotein IIb/IIIa inhibitors are frequently used during percutaneous coronary intervention (angioplasty with or without intracoronary stent placement).